Lannett: Lannett earnings preview: what to expect
Lannett reveals figures for Q2 on February 1.Analysts on Wall Street expect Lannett will release losses per share of $0.410.Go here to follow Lann...
Read full article »
Lannett is a Pennsylvania-based pharmaceutical company that manufactures and commercializes drugs for the treatment of generic diseases.
Read more